Prognostic Factors for Long-Term Survival after Glioblastoma

Prognostic Factors for Long-Term Survival after Glioblastoma


Mohammad Sami Walid, MD, PhD

Fall 2008 - Volume 12 Number 4

https://doi.org/10.7812/TPP/08-027

Abstract

Long-term survivors of glioblastoma (GB) are rare. Several variables besides tumor size and location determine a patient’s survival chances: age at diagnosis, where younger patients often receive more aggressive treatment that is multimodal; functional status, which has a significant negative correlation with age; and histologic and genetic markers.

Introduction


Of the estimated 17,000 primary brain tumors diagnosed in the US each year, approximately 60% are gliomas.1,2 Glioblastoma (GB), or grade IV astrocytoma, is the most aggressive of primary tumors of the brain for which no cure is available.1,3 Management remains palliative and includes surgery, radiotherapy, and chemotherapy. With optimal treatment, patients with GBs have a median survival of less than one year.1 About 2% of patients survive three years.4 Previously reported long-term survivors (LTSs) of GB may have been patients who actually harbored other low-grade gliomas.5 The overall prognosis for GB has changed little since the 1980s, despite major improvements in neuroimaging, neurosurgery, radiotherapy, and chemotherapy techniques.

The Permanente Journal

Sponsored by the eight Permanente Medical Groups, The Permanente Journal advances knowledge in scientific research, clinical medicine, and innovative health care delivery.

Reprint Permissions

The Permanente Journal welcomes requests for reprints and reproduction. Use of any and all material published in The Permanente Journal is copyrighted and protected.

The Permanente Press

The Permanente Press publishes The Permanente Journal and books related to healthcare. Journal subscriptions are entered for the calendar year. Advance payment in US dollars is required.


ISSN 1552-5775 Copyright © 2018 thepermanentejournal.org.

The Permanente Press. All Rights Reserved.